Physician profile
Vishal A Khemlani
NPI 1912346461
$337,539.39
in general payments reported to CMS, 2019-2025
31 companies · $81K in 2025
The $81K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $9,354 · 2020: $13K · 2021: $24K · 2022: $80K · 2023: $70K · 2024: $61K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $145K · Travel and Lodging: $27K · Food and Beverage: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $145,385.00 |
| Travel and Lodging | $27,263.08 |
| Food and Beverage | $19,603.44 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,945.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $136,997.50 | 2019-2024 | Mild Device Kit |
| Stryker Corporation | $79,562.62 | 2019-2025 | Mild Device Kit, Optablate, Spinejack |
| Nalu Medical, INC. | $49,981.20 | 2021-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $35,485.39 | 2019-2025 | Proclaim, Eterna, Infinity |
| Biotronik Nro, INC. | $12,106.64 | 2023-2025 | Prospera, Biotronik |
| Nevro Corp. | $9,552.11 | 2019-2024 | Senza |
| Boston Scientific Corporation | $4,645.88 | 2019-2025 | General - Pain Management, General - Therapies |
| Biotronik INC. | $3,877.00 | 2021-2025 | Prospera |
| Vertiflex, INC. | $2,552.84 | 2019 | |
| Medtronic, INC. | $803.14 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Painteq LLC | $223.93 | 2021-2022 | |
| Saluda Medical Americas, INC. | $214.51 | 2021-2025 | Evoke, Evoke Scs |
| Globus Medical, INC. | $170.03 | 2025 | Senza |
| Lenoss Medical INC | $169.05 | 2025 | Osteopearl |
| Spr Therapeutics, INC | $155.00 | 2021-2023 | Sprint Pns System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $137.83 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Spinal Simplicity, LLC | $135.67 | 2021 | |
| Relievant Medsystems, INC. | $111.01 | 2021-2022 | |
| Si-Bone, INC. | $107.72 | 2024 | |
| Abbvie INC. | $104.77 | 2022-2024 | |
| Stimwave Technologies Incorporated | $104.50 | 2019-2020 | |
| Radius Health, INC. | $69.79 | 2021-2023 | Tymlos |
| Avanos Medical | $52.05 | 2021-2025 | Generator |
| Merit Medical Systems INC | $49.20 | 2020-2021 | |
| Pfizer INC. | $39.10 | 2023-2024 | |
| Allergan, INC. | $28.77 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $27.40 | 2024 | Dysport |
| Stratus Medical, LLC | $25.38 | 2023 | Nimbus |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.61 | 2022 | |
| Grt US Holding, INC. | $14.39 | 2022 | |
| Depuy Synthes Sales INC. | $14.36 | 2023 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$58.27 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Khemlani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.